SMTL ID : 8b91.1 (1 other biounit)

Crystal structure of mutant PPARG (C313A) and NCOR2 with an inverse agonist (compound SI-1)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.23 Å

Oligo State

hetero-1-1-mer

Ligands

1 x Q4O: ~{N}3-[4-[bis(fluoranyl)methoxy]-3-fluoranyl-phenyl]-4-chloranyl-6-fluoranyl-~{N}1-[(2-methoxyphenyl)methyl]benzene-1,3-dicarboxamide(Non-covalent)

Q4O.1: 17 residues within 4Å: Chain A: I.51, L.57, E.61, F.66, R.82, I.83, G.86, A.87, R.90, A.94, I.128, M.131, L.132, L.135, I.143, M.150, M.166 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:I.51, A:L.57, A:E.61, A:F.66, A:F.66, A:A.87, A:L.135, A:I.143 Hydrogen bonds: A:I.83, A:R.90, A:R.90 Water bridges: A:S.144

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Orsi, D.L. et al., Discovery and characterization of orally bioavailable 4-chloro-6-fluoroisophthalamides as covalent PPARG inverse-agonists. Bioorg.Med.Chem. (2022)

Release Date

2022-12-28

Peptides

Peroxisome proliferator-activated receptor gamma: A
Nuclear receptor corepressor 2: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

Peroxisome proliferator-activated receptor gamma

Nuclear receptor corepressor 2

Related Entries With Identical Sequence